AbbVie (ABBV) Interest Coverage Ratio (2012 - 2016)
AbbVie (ABBV) reported Interest Coverage Ratio of 0.37 for Q2 2016, down 118.75% year-over-year from 1.96 in Q3 2015, and down 103.47% quarter-over-quarter from 10.6 in Q1 2016.
AbbVie (ABBV) Interest Coverage Ratio (2012 - 2016) Analysis & Trends
AbbVie (ABBV) has 5 years of Interest Coverage Ratio data on file, last reported at 0.37 in Q2 2016.
- Interest Coverage Ratio for Q2 2016 came in at 0.37, down 118.75% year-over-year; the trailing twelve-month figure through Mar 2017 was 28.54 (up 246.11% YoY), and the FY2015 annual result was 10.48, up 31.84% from the prior year.
- Interest Coverage Ratio eased to 0.37 in Q2 2016 per ABBV's latest filing, from 10.6 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 159.6 in Q3 2012 and troughed at 2.99 in Q4 2014.
- A 5-year average of 21.39 and a median of 15.45 in 2013 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2015 and 2016: Interest Coverage Ratio surged 440.25% in 2015, then sank 118.75% in 2016.
- A 5-year view of Interest Coverage Ratio shows it stood at 19.37 in 2012, then gained by 7.08% to 20.74 in 2013, then plunged by 114.39% to 2.99 in 2014, then surged by 440.25% to 10.16 in 2015, then tumbled by 103.62% to 0.37 in 2016.
- Business Quant data shows ABBV's Interest Coverage Ratio at 0.37 in Q2 2016, 10.6 in Q1 2016, and 10.16 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | -13.73 |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | 23.39 |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | - |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | - |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | 4.06 |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 10.78 |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | - |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | -0.37 |
| Mar 31, 2016 | 10.60 |
| Dec 31, 2015 | 10.16 |
| Sep 30, 2015 | 9.11 |
| Jun 30, 2015 | 1.96 |
| Mar 31, 2015 | 12.78 |
| Dec 31, 2014 | -2.99 |
| Sep 30, 2014 | 6.49 |
| Jun 30, 2014 | 20.75 |
| Mar 31, 2014 | 19.30 |
| Dec 31, 2013 | 20.74 |
| Sep 30, 2013 | 18.28 |
| Jun 30, 2013 | 18.39 |
| Mar 31, 2013 | 18.13 |
| Dec 31, 2012 | 19.37 |
| Sep 30, 2012 | 159.60 |